Turn Therapeutics Inc. Common Stock (TTRX) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Turn Therapeutics Inc. Common Stock (TTRX) has a cash flow conversion efficiency ratio of -1.344x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-923.36K) by net assets ($686.89K). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Turn Therapeutics Inc. Common Stock (TTRX) market capitalisation for the company's overall valuation and market capitalisation.
Turn Therapeutics Inc. Common Stock - Cash Flow Conversion Efficiency Trend (2023–2025)
This chart illustrates how Turn Therapeutics Inc. Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Turn Therapeutics Inc. Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Turn Therapeutics Inc. Common Stock ranked by their cash flow conversion efficiency. Explore how high is Turn Therapeutics Inc. Common Stock's earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Ressources Minieres Radisson Inc
V:RDS
|
0.005x |
|
Symtek Automation Asia Co Ltd
TW:6438
|
0.039x |
|
Ciwen Media Co Ltd
SHE:002343
|
-0.057x |
|
Dynasty Ceramic Public Company Limited
BK:DCC
|
0.037x |
|
Kaveri Seed Company Limited
NSE:KSCL
|
-0.083x |
|
Grupo Traxión S.A.B. de C.V
MX:TRAXIONA
|
0.047x |
|
Hwail Pharmaceutical Co.Ltd
KQ:061250
|
0.033x |
|
Clearfield Inc
NASDAQ:CLFD
|
0.040x |
Annual Cash Flow Conversion Efficiency for Turn Therapeutics Inc. Common Stock (2023–2025)
The table below shows the annual cash flow conversion efficiency of Turn Therapeutics Inc. Common Stock from 2023 to 2025. View Turn Therapeutics Inc. Common Stock (TTRX) stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $4.69 Million | $-2.56 Million | -0.547x | -107.13% |
| 2024-12-31 | $-177.43K | $-1.36 Million | 7.672x | +147.76% |
| 2023-12-31 | $85.77K | $-1.38 Million | -16.063x | -- |
About Turn Therapeutics Inc. Common Stock
Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and de… Read more